World Investment Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.9M Buy
30,399
+2,109
+7% +$693K 0.14% 163
2025
Q4
$9.92M Buy
28,290
+1,597
+6% +$540K 0.16% 148
2025
Q3
$8.62M Sell
26,693
-741
-3% -$230K 0.18% 133
2025
Q2
$10.7M Buy
27,434
+3,988
+17% +$1.6M 0.24% 91
2025
Q1
$10.2M Buy
23,446
+2,909
+14% +$1.17M 0.26% 85
2024
Q4
$7.58M Buy
20,537
+3,509
+21% +$1.47M 0.21% 113
2024
Q3
$8.85M Buy
+17,028
New +$9.1M 0.28% 90

Other funds holding ELV

World Investment Advisors's ELV Position: Q1 2026 in Review

World Investment Advisors increased its Elevance Health (ELV) stake by 7.5% in Q1 2026, buying an estimated $693K and bringing the position to 30,399 shares worth $8.9M. The position accounts for 0.14% of the portfolio, ranked #163.

World Investment Advisors first reported a position in ELV in Q3 2024 and has held it in 7 quarters since. The position peaked at $10.7M in Q2 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • World Investment Advisors held 30,399 shares of Elevance Health worth $8.9M as of Q1 2026.
  • World Investment Advisors bought 2,109 Elevance Health shares in Q1 2026, an estimated $693K.
  • Elevance Health made up 0.14% of World Investment Advisors's portfolio in Q1 2026, its #163 holding.
  • World Investment Advisors first reported a position in Elevance Health in Q3 2024 and has held it in 7 quarters since.
  • World Investment Advisors's Elevance Health position peaked at $10.7M in Q2 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on World Investment Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.